CREG1 enhances p16(INK4a) -induced cellular senescence
Benchamart Moolmuang1, Michael A Tainsky
1Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Cell Cycle (Georgetown, Tex.)
|January 26, 2011
Summary
Cellular Repressor of E1A-stimulated Genes 1 (CREG1) is downregulated in immortal Li-Fraumeni Syndrome cells. CREG1 enhances p16INK4a-induced senescence by repressing cell cycle genes.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Biology
Background:
- Cellular senescence is a crucial barrier against cancer, preventing cells from becoming immortal.
- Bypassing senescence is essential for oncogenic transformation.
- Li-Fraumeni Syndrome (LFS) is associated with increased cancer risk due to impaired tumor suppression.
Purpose of the Study:
- To investigate the role of Cellular Repressor of E1A-stimulated Genes 1 (CREG1) in the immortalization of Li-Fraumeni Syndrome (LFS) fibroblasts.
- To elucidate the mechanism by which CREG1 affects cell proliferation and senescence.
- To explore the combined effect of CREG1 and p16INK4a in cancer cell lines.
Main Methods:
- Analysis of CREG1 expression during spontaneous immortalization of LFS fibroblasts.
- Investigation of epigenetic regulation of CREG1, including promoter DNA methylation.
- Ectopic expression of CREG1 in immortal LFS cell lines and cancer cell lines (osteosarcoma, fibrosarcoma).
- Coexpression studies with p16INK4a and assessment of cell proliferation, cell cycle arrest, and senescence.
- Analysis of cyclin A and cyclin B expression and promoter activity.
Main Results:
- CREG1 expression decreases during LFS fibroblast immortalization and increases during senescence.
- CREG1 repression is mediated by epigenetic DNA methylation.
- Ectopic CREG1 expression reduces proliferation in immortal LFS cells but does not induce senescence alone.
- Coexpression of CREG1 and p16INK4a synergistically reduces cell growth, induces cell cycle arrest, and promotes senescence in LFS fibroblasts and cancer cell lines.
- CREG1 and p16INK4a cooperate to inhibit cyclin A and cyclin B expression by repressing their promoter activity.
Conclusions:
- CREG1 plays a role in preventing cellular immortalization.
- CREG1 acts epigenetically via DNA methylation.
- CREG1 enhances p16INK4a-mediated cellular senescence.
- The combined action of CREG1 and p16INK4a suppresses the expression of key cell cycle regulators, offering a novel therapeutic target for cancers associated with LFS.
Related Concept Videos
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...

